Teva's Planned Generic Aloxi Infringes Helsinn IP, Judge Says
A New Jersey federal judge on Monday ruled that Teva Pharmaceuticals USA Inc. is infringing four patents covering Helsinn Healthcare SA's anti-nausea drug Aloxi and blocked Teva from releasing its planned...To view the full article, register now.
Already a subscriber? Click here to view full article